what happens when you stop retatrutide Long-Term Use: Can Stay On It All Year? Exploring Retatrutide: Risks and Research

Novo Nordisks Response to JAMA Study and Allegations In an emailed statement, Wegovy manufacturer Novo Nordisk countered that there were several limitations of the JAMA study design, which was not a randomized controlled trial, as reported by Reuters

Using advanced multi-omics technologies, the team identified widespread molecular effects across multiple organs, including the brain and heart, suggesting that GLP-1RAs may exert broad protective effects when it comes to brain health and systemic ageing

While it is too early to call an end to compounding, potential intervention by the FDA and DOJ could support the branded GLP-1 market, Flynn says

It helps prevent brain atrophy (loss of neurons in the brain) which eventually prevents dementia and memory loss

By lowering the inflammation burden, the MD may help improve tolerability and enhance semaglutides efficacy in improving glycaemic and metabolic outcomes, especially in patients with high inflammatory burden, metabolic syndrome, or comorbid inflammatory conditions [125, 126]

Understanding GLP-1 Agonists Originally developed for diabetes, GLP-1 medications mimic hormones that help regulate appetite and blood sugar